Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 21 - Number 3

Review Article (Mini-Review)

Acid Ceramidase, a Double-edged Sword in Cancer Aggression: A Minireview

, 21(3): 177 - 191

Helen Shiphrah Vethakanraj, Niveditha Chandrasekaran and Ashok Kumar Sekar*


DOI: 10.2174/1568009620666201223154621



Review Article (Mini-Review)

MALAT1 as a Versatile Regulator of Cancer: Overview of the Updates from Predatory Role as Competitive Endogenous RNA to Mechanistic Insights

, 21(3): 192 - 202

Ammad Ahmad Farooqi*, Evangelia Legaki, Maria Gazouli, Silvia Rinaldi and Rossana Berardi


DOI: 10.2174/1568009620999200730183110



Research Article

Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study

, 21(3): 203 - 212

Irina R. Gilyazova, Narasimha M. Beeraka, Elizaveta A. Klimentova, Kirill V. Bulygin, Vladimir N. Nikolenko, Adel A. Izmailov, Gulshat R. Gilyazova, Valentin N. Pavlov, Elsa K. Khusnutdinova, Siva G. Somasundaram, Cecil E. Kirkland and Gjumrakch Aliev*


DOI: 10.2174/1568009620666201120151226



Research Article

Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs- TRAIL) Increases Antitumor Efficacy of Their Secretome

, 21(3): 213 - 222

Valentina Coccè, Arianna Bonomi, Loredana Cavicchini, Francesca Sisto, Aldo Giannì, Giampietro Farronato, Giulio Alessandri, Francesco Petrella, Valeria Sordi, Eugenio Parati, Gianpietro Bondiolotti, Francesca Paino and Augusto Pessina*


DOI: 10.2174/1568009620666201116112153



Research Article

Selective Antitumor Effect of Shikonin Derived DMAKO-20 on Melanoma through CYP1B1

, 21(3): 223 - 231

Junqi Cui, Xiaobo Zhou, Jia Huang, Jiahua Cui* and Jun Chen*


DOI: 10.2174/1568009620666201116112937



Research Article

Targeted Biological Effect of An Affitoxin Composed of an HPV16E7 Affibody Fused with Granzyme B (ZHPV16E7-GrB) Against Cervical Cancer In vitro and In vivo

, 21(3): 232 - 243

Wenhuan Wang, Xiaochun Tan, Jie Jiang, Yiqi Cai, Fangfang Feng, Lifang Zhang* and Wenshu Li*


DOI: 10.2174/1568009620666201207145720



Research Article

Concomitant Expression of Inhibitory Molecules for T cell Activation Predicts Poor Survival in Patients with Esophageal Squamous Cell Carcinoma

, 21(3): 244 - 253

Zhijun Chen, Kexin Cao, Jinghang Zhang, Zhuangzhuang Liu, Liaoxun Lu, Bo Qi, Lijin Shi, Rong Huang* and Song Zhao*


DOI: 10.2174/1568009620666201120152333



Research Article

Forkhead-box A3 (FOXA3) Represses Cancer Stemness and Partially Potentiates Chemosensitivity by Targeting Metastasis-Associated in Colon Cancer 1 (MACC1) Signaling Pathway in Colorectal Cancer Cells

, 21(3): 254 - 267

Na Li*, Yun Li, Hongbo Gao, Jing Li, Xiaoping Ma, Xiaomei Liu, Ping Gong, Xiaobin Cui and Yong Li*


DOI: 10.2174/1568009620666201207150632




Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog